Abstract:Objective:The aim of this study was to evaluate whether a predictive model based on a contrast enhanced ultrasound (CEUS)-based nomogram and clinical features (Clin) could differentiate Her-2-overexpressing breast cancers from other breast cancers. Methods:A total of 152 pathology-proven breast cancers including 55 Her-2-overexpressing cancers and 97 other cancers from two units that underwent preoperative CEUS examination, were included and divided into training (n = 102) and validation cohorts (n = 50). Multivariate regression analysis was utilized to identify independent indicators for developing predictive nomogram models. The area under the receiver operating characteristic (AUC) curve was also calculated to establish the diagnostic performance of different predictive models. The corresponding sensitivities and specificities of different models at the cutoff nomogram value were compared. Results:In the training cohort, 7 clinical features (menstruation, larger tumor size, higher CA153 level, BMI, diastolic pressure, heart rate and outer upper quarter (OUQ)) + enlargement in CEUS with P < 0.2 according to the univariate analysis were submitted to the multivariate analysis. By incorporating clinical information and enlargement on the CEUS pattern, independently significant indicators for Her-2-overexpression were used for further predictive modeling as follows: Model I, nomogram model based on clinical features (Clin); Model II, nomogram model combining enlargement (Clin + Enlargement); Model III, nomogram model based on typical clinical features combining enlargement (MC + BMI + diastolic pressure (DP) + outer upper quarter (OUQ) + Enlargement). Model II achieved an AUC value of 0.776 at nomogram cutoff score value of 190, which was higher than that of the other models in the training cohort without significant differences (all P>0.05). In the test cohort, the diagnostic efficiency of predictive model was poor (all AUC<0.6). In addition, the sensitivity and specificity were not significantly different between Models I and II (all P>0.05), in either the training or the test cohort. In addition, Clin exhibited an AUC similar to that of model III (P=0.12). Moreover, model III exhibited a higher sensitivity (70.0%) than the other models with similar AUC and specificity, only in the test cohort. Conclusion:The main finding of the study was that the predictive model based on a CEUS-based nomogram and clinical features could not differentiate Her-2-overexpressing breast cancers from other breast cancers.

A Diagnostic Model for Breast Lesions with Enlarged Enhancement Extent on Contrast-Enhanced Ultrasound Improves Malignancy Prediction

A Nomogram Based on Combining Clinical Features and Contrast Enhanced Ultrasound is Not Able to Identify Her-2 Over-Expressing Cancer from Other Breast Cancers.

Predictive Model for Contrast-Enhanced Ultrasound of the Breast: is It Feasible in Malignant Risk Assessment of Breast Imaging Reporting and Data System 4 Lesions?

Value of Scoring by Contrast-Enhanced Ultrasound Combined with Ultrasonic Elastography in Differential Diagnosis of BI-RADS 4 Lesions

Factors Influencing the Performance of a Diagnostic Model Including Contrast-Enhanced Ultrasound in 1023 Breast Lesions: Comparison with Histopathology.

Combination of conventional ultrasound with quantitative and qualitative analyses of CEUS for the differentiation of benign and malignant breast solid lesions: A modified breast cancer model

A Multicenter Study of a Contrast-Enhanced Ultrasound Diagnostic Classification of Breast Lesions

Predictive Value of Contrast-Enhanced Ultrasound Combined with Conventional Ultrasound in Solid Renal Parenchymal Lesions.

Application Value of Predictive Models of Contrast-Enhanced Ultrasound in the Evaluation of Breast Imaging Reporting and Data System 4 Breast Lesions

Multimodal Ultrasound Imaging in Breast Imaging-Reporting and Data System 4 Breast Lesions: A Prediction Model for Malignancy

Contrast-Enhanced Ultrasonography Features Of Breast Malignancies With Different Sizes: Correlation With Prognostic Factors

Evaluation of Contrast-Enhanced Ultrasonography Breast Predictive Model in Optimizing Breast Lesions BI-RADS Classification

Value of an Expanded Range of Lesions on Contrast-Enhanced Ultrasound for the Diagnosis of Hypervascular Breast Masses.

Enhancing Early Breast Cancer Diagnosis with Contrast-Enhanced Ultrasound Radiomics: Insights from Intratumoral and Peritumoral Analysis

Contrast-Enhanced Cone-Beam Breast CT: An Analysis of Diagnostic Value in Predicting Breast Lesion With Rim Enhancement Malignancy

A Conditional Inference Tree Model for Predicting Cancer Risk of Non-Mass Lesions Detected on Breast Ultrasound.

Correlation Analysis between Expression Profiles of Molecular Markers and Contrast-Enhanced Ultrasound Parameters in Breast Cancer

Multi-parameter ultrasonography-based predictive model for breast cancer diagnosis

The role of contrast-enhanced ultrasound in the diagnosis of malignant non-mass breast lesions and exploration of diagnostic criteria

Non-mass Breast Lesions: Could Multimodal Ultrasound Imaging Be Helpful for Their Diagnosis?

Evaluation of Breast Lesions by Contrast Enhanced Ultrasound: Qualitative and Quantitative Analysis.